Global status and trends in heart failure with preserved ejection fraction over the period 2009-2020: A bibliometric

Qiuju Dong1, Junwei Zhang, Qinghua Han

  • 1Hospital of Integrated Traditional and Western Medicine, Shanxi University of Chinese Medicine, Taiyuan, Shanxi, China,Third Clinical College, Shanxi University of Chinese Medicine, Taiyuan, Shanxi, China,The Key Research Laboratory of Benefiting Qi for Acting Blood Circulation Method to Treat Multiple Sclerosis of State Administration of Traditional Chinese Medicine, Research Center of Neurobiology, Shanxi University of Chinese Medicine, Jinzhong, Shanxi, China,School of Management, Shanxi Medical University, Jinzhong, Shanxi, China,School of Computer and Information Technology, Shanxi University, Taiyuan, Shanxi, China,First Hospital, Shanxi Medical University, Taiyuan, Shanxi, China.

Medicine
|March 31, 2022
PubMed

Insights

This bibliometric analysis of heart failure with preserved ejection fraction (HFpEF) research from 2009-2020 reveals increasing global output. Key research areas include diagnosis, outcomes, and diastolic dysfunction, with emerging trends in inflammation and phenotype.

Area of Science:

  • Cardiology
  • Bibliometrics
  • Medical Research

Background:

  • Heart failure with preserved ejection fraction (HFpEF) accounts for 50% of heart failure cases.
  • Currently, no effective treatment strategies exist for HFpEF.
  • This study analyzes scientific literature on HFpEF from 2009-2020.

Purpose of the Study:

  • To evaluate global scientific output in HFpEF research.
  • To explore the current research status and emerging trends in HFpEF.
  • To provide guidance for researchers in the HFpEF field.

Main Methods:

  • Bibliometric analysis of 1971 documents (articles and reviews) published between 2009-2020.
  • Data retrieved from Science Citation Index Expanded (SCIE) in Web of Science.
  • Analysis conducted using bibliometrix R-package, VOSviewer, and CiteSpace.

Main Results:

  • Annual document output increased from 24 to 353.
  • USA led in publications, with Mayo Clinic as a leading institution.
  • Key terms: mortality, dysfunction, diagnosis, outcomes, diastolic dysfunction; Emerging trends: hemodynamics, comorbidity, inflammation, phenotype.

Conclusions:

  • Bibliometric analysis provides a comprehensive overview of HFpEF research productivity.
  • Identifies research hotspots, frontiers, and potential collaborators.
  • Offers valuable guidance for future in-depth HFpEF research.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
82
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
57
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
95
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
36
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
67